Among the semisynthetic penicillins, ampicillin, 6 -(>-a-aminophenylacetamido)penicillanic acid, has found widespread use owing to its broad-spectrum type of activity. It is orally absorbed, though only partially, to give urinary recoveries from 30 to 50% of the active compound (11) . Certain esters of ampicillin, namely, pivampicillin (5) and talampicillin (4, 12) , have been found to be well absorbed when given orally and undergo hydrolysis in the body to give peak levels of ampicillin higher than those obtained with ampicillin itself. These esters are analogues of acyloxyalkyl esters, first described by Jansen and Russell (8) . We now describe a new type of hydrolyzable ester group containing a carbonate moiety with which it is possible to improve the oral absorption of ampicillin and other types of 8-lactam antibiotics. Among a series of ampicillin esters containing this structure, one compound, 1'-ethoxycarbonyloxyethyl 6-(D-a-aminophenylacetamido)penicillanate (bacampicillin) (Fig. 1 [T5S]bacampicillin and [35S]ampicillin were prepared from [PS] benzylpenicillin obtained by fermentation and had specific activities of 18.8 s-' nmol-1.
Their radiochemical purities as checked by thinlayer chromatography were greater than 95%.
Analytical methods. Paper chromatograms were run in an n-butanol-ethanol-water (4:1:5, top layer, vol/vol/vol) system using microbiological detection with a Bacillus cereus strain. Thin-layer chromatography of the radioactive compounds was performed on silica gel plates (Merck) using an n-butanolacetic acid-water (4:1:4, top layer) system. Detection was by autoradiography (Structuric X-ray film, Agfa-Gevaert).
Radioactivity was assayed using a liquid scintillation spectrometer (Packard Tri-Carb, model 3320).
The scintillation liquid consisted of butyl 2-(4-tertbutylphenyl)-5-(4-biphenylyl)-1,3,4-oxadiazole (7.0 g), ethylene glycol monoethyl ether (600 ml), and toluene (1,000 ml). juice, 20 ug/ml). All media and accessories necessary for the procedure were preheated to 37 C, and test solutions were immediately incubated at 37 C. Zero samples were taken from the phosphate buffer solutions before incubation. After 30 min, aliquots (2 ml) of the solutions were shaken vigorously with their own volume of ethyl acetate to remove unhydrolyzed ester. The samples from the synthetic gastric juice were neutralized with 0.2 N disodium phosphate before extraction. After the extraction, the amount of ampicillin in the aqueous phase was determined microbiologically by an agar diffusion method with Sarcina lutea as the test organism (7).
(ii) Whole blood and plasma. To heparinized human blood or plasma (10.0 ml), or dog plasma (15.0 ml), at 37 C, [FS] bacampicillin hydrochloride (2 and 3 ,umol, respectively) was added, dissolved in preheated physiological saline (1.0 ml), to give a final concentration of about 100 ,ug/ml. Aliquots (1.0 ml) were taken from the incubation mixture at intervals up to 30 min, starting 1 min after mixing, and immediately chilled in an ice bath. In the case of whole blood the samples were hemolyzed with 1% saponin solution (1 ml) for 10 s. The unchanged drug was immediately extracted into methylene chloride (3.0 ml) by vigorous shaking for 2 min, followed by centrifugation. The clear organic phase was washed with phosphate buffer solution (V15 mol/liter, pH 7.5; 1.0 ml) followed by centrifugation. For assay of the radioactivity, 1.0 ml of the clear organic phase was mixed with scintillation liquid (16 ml).
The extraction efficiency of bacampicillin from whole blood was determined to 100% (range 95 to 105%; n = 6). Ampicillin, added to a concentration of 100 Ag/ml, was co-extracted into the organic phase to an extent of 0.23% (range 0.20 to 0.25%; n = 5).
First 10 and 15 min, respectively, after administration and analyzed for unchanged ester.
An aliquot (1.0 ml) of the ice-cooled heparinized whole blood was hemolyzed by addition of saponin solution (1 ml) containing unlabeled bacampicillin (100 j.g). After 10 s, the unchanged drug was extracted into methylene chloride (3.0 ml) by vigorous shaking for 2 min, followed by centrifugation. The clear organic phase was washed with phosphate buffer solution (1115 mol/liter, pH 7.5; 1.0 ml) by shaking and centrifugation. The radioactivity of the clear organic phase was determined after mixing an aliquot (1.0 ml) with scintillation liquid (16 ml).
( ) per kg, respectively, in total radioactive doses of 7.5 x 105 s'lkg'1. The compounds were given as 4-mM solutions in physiological saline (phosphate buffer, 1/15 mol/liter, added to pH 8.0 to dissolve ampicillin). After dosing, the animals were kept by group in metabolism cages with free access to food and water. Blood samples were withdrawn by cardiac puncture and plasma was prepared. The urine and feces samples from each subgroup were pooled. All samples were stored at -25 C before analysis.
The total radioactivity of the blood, plasma, urine, and feces was determined according to a modification of the method of Mahin and Lofberg (9) . An aliquot (about 100 mg) of the sample was dissolved in perchloric acid (0.20 ml) to which hydrogen peroxide (0.20 ml) was added. The samples, contained in capped counting vials, were placed in an oven at 70 C for 1 h. After cooling to -25 C, scintillation solution (16 ml) was added.
The concentration of penicillin in plasma and urine was determined by the cylinder plate method (7) using S. lutea as the test organism. The standard solutions for plasma were prepared in rat serum, and those for urine were prepared in Sorensen's phosphate buffer, pH 7.0. The samples were diluted with the same diluents.
(ii) Dogs. 72 , and 96 h after administration. Plasma was prepared. Urine was sampled by catheterization before and 2, 4, and 8 h after administration and collected, as was the feces, 24, 48, 72, and 96 h after administration. All samples were stored at -25 C before being analyzed as above.
Penetration into tissue fluid. The method used was a modification of that described by Gardner (6) . White female SPF rats weighing about 100 g were anesthetized intraperitoneally with 50% pentobarbital in physiological saline (0.1 ml) and subcutaneously with 2% Xylocaine (0.5 ml) along the line of incision to be made. The backs were clipped and cleansed with 70% alcohol before a 2.5-cm longitudinal cut was made from the shoulders to the lumbar area. The skin was opened on both sides of the cut just enough to insert two sterilized coil springs (2 by 1 cm; 1-mm soft, stainless-steel wire) subcutaneously, one on each side of the spine. The incision was closed with sutures and covered with surgical tape to prevent infection, Each rat was placed in a separate cage and given food and water ad lib. After 3 weeks the rats were ready for the experiment.
Twenty-four fasting rats were each given orally equimolar amounts (270 Zimol/kg) of sodium ampicillin (100 mg/kg) or bacampicillin hydrochloride (135 mg/kg) dissolved in distilled water (0.5 ml). Each animal also received heparin solution (0.5 ml) subcutaneously. At specific times, about 0.1-ml transudate samples were taken by needle aspiration from any one of the two coil springs of each rat, and immediately afterwards a 0.01-ml sample of blood was taken from the left orbital sinus by micropipette after puncture with a long needle. Six animals were used at each sampling time, and samples were taken from each animal on two consecutive occasions only. Transudate samples visibly contaminated with blood were discarded.
The blood samples were diluted 100 times in distilled water and assayed by the cylinder plate method (7) using S. lutea as the test organism and ampicillin as the standard penicillin. The sensitivity limit of the assay was 1 ,ug of undiluted sample per ml. The transudate samples were added dropwise to paper disks (6 mm; Grycksbo 33D), six disks for each sample, and assayed by the paper disk method (13) with S. lutea as test organism and ampicillin as standard penicillin. The standard disks were each pretreated with a drop of transudate from animals not treated with penicillin before applying the standard dilutions. The sensitivity limit of the assay was 0.1 ,ug/ml.
Distribution into organs of the rat. Female fasting SPF rats weighing about 100 g were given orally equimolar doses (270 umolIkg) of bacampicillin hydrochloride (135 mg/kg) and sodium ampicillin (100 mg/kg) dissolved in distilled water. At specific times after administration, the animals were killed, four at each time, and the spleen, kidneys, and liver were taken out in that order and immediately placed in preweighed cylinders containing 3 ml (spleen and kidneys) or 10 ml (livers) of distilled water. All organs and samples were stored at -20 C until analyzed. The organs were homogenized by a highspeed stirrer (Ultra-Turrax) and assayed for their ampicillin content by the cylinder plate method using S. lutea as test organism. The liver and kidney homogenates were diluted 10 times with distilled water before analysis, whereas the spleen homogenates were analyzed undiluted.
Experimental infections. (Fig. 2) .
The hydrolysis of bacampicillin to ampicillin in vivo was investigated in rats and dogs given oral doses of 20 mg of [35Slbacampicillin per kg. Although the analytical procedure used would allow detection of blood levels of bacampicillin as low as 0.02 ,ug/ml, i.e., about 0.5% or lower of the peak blood levels of ampicillin obtained, no evidence of the compound circulating in the blood was obtained, indicating that the hydrolysis of bacampicillin to ampicillin in vivo was very rapid and extensive and in effect occurred in connection with the oral absorption process.
Oral absorption. After oral administration to rats, bacampicillin was rapidly absorbed to give earlier and much higher peak levels of ampicillin compared to ampicillin itself (Fig. 3) In rats as well as in dogs, the levels ofradioactivity in plasma and urine were higher for both compounds than those of biological activity. This was due to biotransformation of ampicillin, leading mainly to antibacterially inactive penicilloate. The recovery of radioactivity was complete for both compounds. The amounts not accounted for in the urine were excreted with the feces.
Distribution. Since only ampicillin, not ba- campicillin, could be found circulating in the blood after oral administration ofthe latter, the antibiotic being distributed in the body must be ampicillin. The penetration of it into organs and tissues after oral administration of bacampicillin and ampicillin was compared in two studies in rats receiving equimolar amounts (270 ,umol/kg) of the two compounds. The peak blood levels obtained with this dose again appeared higher after bacampicillin than after 10. (Table 3 ; Fig. 4) , and for both compounds they were in good agreement with those to be expected from the plasma levels of the previous study with a lower dose (Fig. 3) .
The penetration into tissue fluid was studied in an experimental model comprising "tissue cages" formed by implantation of coil springs in the backs of the rats (1, 6) . The serous fluid, transudate, formed in similar cages has been assumed to be the equivalent of the interstitial fluid and in communication with it (3). In the experiment which comprised observations on four groups of animals for each compound, the mean transudate levels were consistently found to be higher after bacampicillin than after ampicillin (Table 3 ; Fig. 4) . The difference was twoto threefold, but it was statistically significant (P < 0.05) only at 2 h after administration. The results further indicated a longer duration of the transudate than of the blood levels for both compounds, with a statistically significant difference (P < 0.05) in the case of bacampicillin 4 h after administration.
Analysis of homogenates of kidney and liver showed three to four times higher levels of ampicillin after administration of bacampicillin than after ampicillin (Table 4 ). In the spleen bacampicillin gave slightly higher levels.
Experimental infections. Orally administered bacampicillin showed good activity against experimental infections in mice caused by various gram-positive and gram-negative bacteria. When the compounds were given directly after the animals had been infected, bacampicillin was found to be as active as, or more active than, ampicillin against nine of the eleven organisms tested (Tables 5 and 6 ).
In one series of experiments with H. influenzae, the penicillins were, however, not given until 4 h after infection. It is likely that under such conditions the infection will be more severe as the bacteria are given time to establish themselves in the tissues of the animals. In In the absorption experiments carried out bacampicillin, according to all criteria used, i.e., blood levels and, urinary and fecal recovery, was found to be more efficiently absorbed orally than ampicillin. The results also suggested a different absorption profile for the former, with earlier and much higher peak blood levels than obtained with the latter.
The concentrations found in the kidney and liver homogenates suggest that the higher initial blood levels obtained with bacampicillin cause a correspondingly higher tissue penetration. In the spleen the levels were lower, although here too they appeared slightly higher after bacampicillin than after ampicillin. The relation to the blood levels was, however, less evident. 35.5 Of further interest is that, for both compounds, 9 .0 the levels in the cages appear more sustained 9.5 than the blood levels, indicating a diffusion 21.0 barrier surrounding the cages. Similar barriers 11.5 are likely to occur around infectional foci in 9.5 tissues, and the results thus suggest that ba- 12.5 campicillin, due to better oral absorption than 13.5 ampicillin, might have pharmacokinetic advan- 
